Yoshihiro Goto

Title: Innovations of Yoshihiro Goto

Introduction

Yoshihiro Goto is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of immunology, particularly in the activation of helper T cells. With a total of six patents to his name, Goto's work has the potential to impact cancer treatment and immunotherapy.

Latest Patents

One of his latest patents is a method for activating helper T cells. This invention involves the activation of helper T cells by adding a WT1 peptide to antigen presenting cells. The WT1 peptide is designed to bind to various MHC class II molecules, including HLA-DRB1*0101, HLA-DRB1*0401, HLA-DRB1*0403, HLA-DRB1*0406, HLA-DRB1*0803, HLA-DRB1*0901, HLA-DRB1*1101, HLA-DRB3*0202, HLA-DRB4*0101, HLA-DPB1*0201, and HLA-DPB1*0301. This innovative approach could enhance the effectiveness of immunotherapies.

Career Highlights

Throughout his career, Yoshihiro Goto has worked with notable organizations, including Otsuka Pharmaceutical Company, Limited and the International Institute of Cancer Immunology, Inc. His experience in these companies has allowed him to develop and refine his innovative ideas in the field of cancer immunology.

Collaborations

Goto has collaborated with esteemed colleagues such as Haruo Sugiyama and Shinji Sogo. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yoshihiro Goto's contributions to the field of immunology through his innovative patents demonstrate his commitment to advancing cancer treatment. His work continues to inspire future research and development in this critical area of medicine.